Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For SUS.L
Valuation Weak
28%
Profitability n.A.
Fin. Growth n.A.
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q4 Δ in %
Current Ratio -41.40 < 0.005 < 0.005
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 14.75 5.97 5.20
Naive Interpretation member
2 Per Share
Metric Q2 Q4 Δ in %
Book Value 2.18 19.27 18.86
Cash 0.00 < 0.005 < 0.005
Capex 68.81 < 0.005 -0.02
Free Cash Flow 78.52 -2.95 1.65
Revenue 8.58 4.95 4.55
Naive Interpretation member
3 Profitability
Metric Q2 Q4 Δ in %
Gross Margin -1.56 0.79 0.80
Operating Margin -2.33 0.62 0.64
ROA -48.37 0.02 0.04
ROE -44.07 0.04 0.07
ROIC -4.22 0.06 0.06
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of SUS.L is permitted for members.
5 Growth
The "Growth Entry" for the Focus of SUS.L is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of SUS.L is permitted for members.